中药治疗尘肺病的meta分析

职业与健康 ›› 2024, Vol. 40 ›› Issue (5): 689-692.

中药治疗尘肺病的meta分析

李诗婷^a, 董蝶雯^a, 郑鑫樑^b, 崔霖^b, 张敏^c

杭州医学院a医学影像学院,b公共卫生学院,c全科医学与继续教育学院,浙江杭州 310053

收稿日期:2023-06-22 修回日期:2023-07-24 发布日期:2026-03-16
通信作者: 张敏,助理研究员,E-mail：zhangm@zjams.com.cn
作者简介:李诗婷,女,在读本科生。
基金资助:
浙江省教育厅一般科研项目（Y202146046）; 杭州医学院院所专项（YS2021013）; 浙江省医药卫生科技计划项目（2021KY131）

Meta-analysis of traditional Chinese medicine in the treatment of pneumoconiosis

LI Shiting^a, DONG Diewen^a, ZHENG Xinliang^b, CUI Lin^b, ZHANG Min^c

a School of Medical Imaging,b School of Public Health,c College of General Practice and Further Education,Hangzhou Medical College,Hangzhou Zhejiang,310053, China

Received:2023-06-22 Revised:2023-07-24 Published:2026-03-16
Contact: ZHANG Min,Research associate,E-mail：zhangm@zjams.com.cn

摘要/Abstract

摘要： 目的了解中药对尘肺病的治疗效果。方法检索2000年12月—2022年6月在国内外医学期刊上发表的中药治疗尘肺病的文献,单纯中药治疗或者中医合并西医治疗为试验组,西医治疗或者安慰剂或者不治疗为对照组。纳入文献17篇,共 1 424例尘肺患者,用Review Manager 5.4进行meta分析。结果试验组与对照组对比,中药治疗能提高患者临床治疗有效率（OR=6.51,95%CI：3.36~12.64）,改善临床呼吸症状（OR=3.29,95%CI：2.50~4.31）、明显改善感染肺部阴影（OR=9.75,95%CI：4.89~19.45）、提高肺功能第1 s用力呼气量（forced expiratory volume in one second,FEV₁）（OR=0.98,95%CI：0.43~1.54）、第1 s用力呼气量占用力肺活量百分比（forced expiratory volume in one second/forced vital capacity,FEV₁/FVC）（OR=6.82,95%CI：4.90~8.74）和第1 s用力呼气容积占预计值百分比（forced expiratory volume in one second/ normal expected value,FEV₁%）（OR=8.66,95%CI：6.57~10.75）、明显增加6 min步行试验（6-minute walking test,6 MWT）（OR=45.71,95%CI：27.21~64.21）,差异均有统计学意义（均P<0.05）。结论中药治疗尘肺病在提高临床治疗有效率、改善临床症状和感染肺部阴影、提高肺功能和增加6MWT等方面有一定优势,但由于纳入研究样本量较少,需要更多高质量研究加以验证。

关键词: 中药, 尘肺病, 治疗, 系统评价

Abstract: Objective To understand the therapeutic effect of traditional Chinese medicine on pneumoconiosis. Methods Literature on the treatment of pneumoconiosis with traditional Chinese medicine published in domestic and foreign medical journals from December 2000 to June 2022 was retrieved. The experimental group was treated with traditional Chinese medicine alone or with traditional Chinese medicine combined with western medicine,and the control group was treated with western medicine or placebo or no treatment. Totally 17 literatures were included,including 1 424 cases of pneumoconiosis,and meta-analysis was performed with Review Manager 5.4. Results Compared with the control group,Chinese medicine treatment can improve the clinical treatment efficiency of patients（OR=6.51,95%CI：3.36-12.64）,improve clinical respiratory symptoms（OR=3.29,95%CI：2.50-4.31）, significantly improve the shadow of infected lung（OR=9.75,95%CI：4.89-19.45）,improve pulmonary function FEV1（OR=0.98, 95%CI：0.43-1.54）,FEV1/FVC（OR=6.82,95%CI：4.90-8.74） and FEV1%（OR=8.66,95%CI：6.57-10.75）,and significantly increase 6MWT（OR=45.71,95%CI：27.21-64.21）,the differences were statistically significance（all P<0.05）. Conclusion Traditional Chinese medicine in the treatment of pneumoconiosis has certain advantages in improving the clinical treatment efficiency,improving clinical symptoms and infected lung shadows,improving lung function and increasing 6MWT. However,due to the small sample size of the included studies,more high-quality studies are needed to verify.

Key words: Traditional Chinese medicine, Pneumoconiosis, Treatment, System assessment

中图分类号:

R181.2

李诗婷, 董蝶雯, 郑鑫樑, 崔霖, 张敏. 中药治疗尘肺病的meta分析. [J]职业与健康, 2024, 40(5): 689-692.

LI Shiting, DONG Diewen, ZHENG Xinliang, CUI Lin, ZHANG Min. Meta-analysis of traditional Chinese medicine in the treatment of pneumoconiosis. [J]OCCUPATION AND HEALTH, 2024, 40(5): 689-692.

参考文献

[1] CHEN M,WANG H,ZHANG J,et al.Distribution of Asbestos Enterprises and Asbestosis Cases-China,1997-2019[J].China CDC Wkly,2020,2(18):305-309.
[2] MIRON O,AFRASANIE V A,PADURARU M I,et al.The relationship between chronic lung diseases and lung cancer-a narrative review[J]. J BUON,2020,25(4):1687-1692.
[3] POINEN S,RUGHOOPUTH M S,GUO Y,et al.Occupational exposure to silica dust and risk of lung cancer:An updated meta-analysis of epidemiological studies[J].BMC Public Health,2016,16(1):1137.
[4] YANG Q,LIN M,HE Z,et al.Mycobacterium tuberculosis infection among 1,659 silicosis patients in Zhejiang Province,China[J].Microbiol Spectr,2022,10(6):e0145122.
[5] JIANG Z,CHEN J,CHEN J,et al.Mortality due to respiratory system disease and lung cancer among female workers exposed to chrysotile in Eastern China:A cross-sectional study[J].Front Oncol,2022,12:928839.
[6] ZHAO J Q,LI J G,ZHAO C X.Prevalence of pneumoconiosis among young adults aged 24-44 years in a heavily industrialized province of China[J].J Occup Health,2019,61(1):73-81.
[7] 吴丽,湛欢,包郑楠,等.湖南省尘肺病患者治疗费用分析[J].中华劳动卫生职业病杂志,2022,40(7):515-518.
[8] 孙志谦,马有陆,刘红梅,等.2011—2021年国内尘肺病治疗研究现状文献计量学分析[J].中国疗养医学,2022,31(11):1135-1139.
[9] 张志玲,何娜,徐晓涵,等.汉防己甲素片治疗尘肺病的药物临床综合评价[J].中华劳动卫生职业病杂志,2023,41(3):217-221.
[10] 曹兴. 布地奈德雾化吸入对尘肺患者大容量全肺灌洗术中呼吸力学的影响[D].唐山:华北理工大学,2020.
[11] 李和林,唐忠权.治疗矽肺并发慢性阻塞性肺疾病38例[J].中华劳动卫生职业病杂志,2011,29(8):617-618.
[12] 尹衍玲,姜玉清,谌晓明,等.瓜芪合剂治疗矽肺的临床研究[J].中华劳动卫生职业病杂志,2000,18(6):372-373.
[13] 李俊成,段宏宪,贾百全,等.中西医结合治疗矽肺的临床观察[J].中国中西医结合急救杂志,2002,9(2):84-85.
[14] 王雪涛,陈玉柱,刘丽华,等.中医辨证分型治疗尘肺的临床观察[J].中国医药,2010,5(4):318-320.
[15] 周镔,周馨,张金霞,等.消尘止咳汤治疗尘肺咳嗽的临床疗效观察[J].中国临床研究,2011,24(10):946-947.
[16] 严沛元,林君祥,纪才书,等.中药汤剂辅治Ⅱ期矽肺病伴肺部感染患者疗效观察[J].河北医科大学学报,2011,32(12):1432-1433.
[17] 缪荣明,房中华.金水宝胶囊治疗矽肺的临床观察[J].中华劳动卫生职业病杂志,2012,30(10):782-783.
[18] 缪荣明,房中华,姚雍铭,等.汉防己甲素联合苦参碱注射液治疗矽肺的疗效观察[J].中华劳动卫生职业病杂志,2012,30(10):778-780.
[19] 丁增学. 清热化痰中药联合吸入用复方异丙托溴铵溶液对煤工尘肺合并慢性阻塞性肺疾病急性加重期患者肺功能及血清白细胞介素-6和白细胞介素-8的影响[J].河北中医,2013,35(3):392-394.
[20] 谢潇侠,王俊霞,李天玲,等.针灸、中药联合康复治疗尘肺病的临床随机对照研究[J].西部中医药,2014,27(8):1-4.
[21] 曾婷. 中药黄根联合N-乙酰半胱氨酸治疗尘肺的疗效及临床分析[J].工业卫生与职业病,2016,42(5):374-375.
[22] 宁建霞,张丽萍,崔瑛,等.汉防已甲素联合乙酰半胱氨酸泡腾片治疗矽肺临床效果评价[J].中华劳动卫生职业病杂志,2017,35(4):298-299.
[23] 苏晓珏,范槐芳,王丽.中西药联合治疗尘肺病37例疗效分析[J].中国基层医药,2017,24(19):2881-2884.
[24] 王丽,范槐芳,童慧娟,等.平喘固本中药热奄包治疗肺肾气虚型尘肺患者的临床观察[J].中国中医药科技,2020,27(5):729-730.
[25] 徐婕,周中华.汉防己甲素治疗矽肺抗肺纤维化作用的研究[J].临床肺科杂志,2015,29(9):1658-1660.
[26] 丁建花,白金,王郡甫.汉防己甲素对矽肺患者抗肺纤维化的作用研究[J].中国医药指南,2018,16(30):12-13.
[27] LI J,ZHAO H,XIE Y,et al.Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis:A pilot double-blind,randomized,and placebo-controlled study[J].Front Med,2022,16(5):736-744.
[28] XU C,ZHAO J,LI Q,et al.Exosomes derived from three-dimensional cultured human umbilical cord mesenchymal stem cells ameliorate pulmonary fibrosis in a mouse silicosis model[J].Stem Cell Research & Therapy,2020,11(1):503.
[29] XU R,ZONG Y,JIANG Y.TCM and western medicine:Diagnosis and treatment of novel coronavirus pneumonia,a case study[J].Altern Ther Health Med,2023,29(2):90-96.
[30] LI J,YU X Q,XIE Y,et al.Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis:An exploratory,randomized,double-blinded and placebo controlled trial[J].Front Pharmacol,2022,13:1053356.